Search Results - "Crockett, MW"

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    Preliminary toxicity results of a phase II trial of adjuvant docetaxel/cyclophosphamide plus trastuzumab in HER2+ early stage breast cancer patients

    Preliminary toxicity results of a phase II trial of adjuvant docetaxel/cyclophosphamide plus trastuzumab in HER2+ early stage breast cancer patients by Jones, SE, Collea, RP, Oratz, R, Paul, D, Sedlacek, SM, Holmes, FA, Portillo, RM, Crockett, MW, Asmar, L, O'Shaughnessy, JA, Robert, NJ

    Published in Cancer research (Chicago, Ill.) (15-01-2009)
    “…Abstract #2111 Background: Docetaxel/cyclophosphamide (TC) has demonstrated superior activity to doxorubicin/cyclophosphamide (AC) in the adjuvant treatment of…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  2. 2
    Phase II study of pegylated liposomal doxorubicin (PLD) and carboplatin (Cb) can be administered with trastuzumab (H) in patients with metastatic breast cancer

    Phase II study of pegylated liposomal doxorubicin (PLD) and carboplatin (Cb) can be administered with trastuzumab (H) in patients with metastatic breast cancer by Collea, RP, Kruter, FW, Cantrell, JE, George, TK, Kruger, S, Favret, AM, Lindquist, DL, Melnyk Jr, AM, Pluenneke, RE, Shao, SH, Crockett, MW, Asmar, L, O'Shaughnessy, JA

    Published in Cancer research (Chicago, Ill.) (15-01-2009)
    “…Abstract #6118 Background: PLD and Cb are active in metastatic breast cancer (MBC) but no data exist regarding the antitumor activity of the combination. Both…”
    Get full text
    Journal Article
    Save to List
    Saved in:

Search Tools: